1. An increased percentage of myeloid CD34+ bone marrow cells stratifies intermediate IPSS‐R myelodysplastic syndrome patients into prognostically significant groups. (18th May 2018) Authors: Chen‐Liang, T.‐H.; Casado‐Prieto, A. M.; Campos‐Rodríguez, V.; Hurtado, A. M.; Amigo, M. L.; García‐Malo, M. D.; Vicente, V.; Ortuño, F. J.; Jerez, A. Journal: International journal of laboratory hematology Issue: Volume 40:Number 5(2018:Oct.) Page Start: 549 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗